Pluri Inc. - Common Stock (PLUR)
4.0300
+0.4100 (11.33%)
NASDAQ · Last Trade: Apr 19th, 6:33 AM EDT
Detailed Quote
Previous Close | 3.620 |
---|---|
Open | 3.650 |
Bid | 4.110 |
Ask | 4.420 |
Day's Range | 3.360 - 4.040 |
52 Week Range | 3.330 - 6.600 |
Volume | 32,129 |
Market Cap | - |
PE Ratio (TTM) | - |
EPS (TTM) | - |
Dividend & Yield | N/A (N/A) |
1 Month Average Volume | 8,031 |
Chart
About Pluri Inc. - Common Stock (PLUR)
Pluri Inc. is a biotechnology company focused on advancing cell therapy and regenerative medicine through its innovative technologies. The company specializes in developing and commercializing products and therapies aimed at treating incurable diseases and addressing unmet medical needs. By harnessing the power of pluripotent stem cells and advanced genetic engineering techniques, Pluri seeks to transform the landscape of medical treatment, offering new hope for patients suffering from a range of conditions. Their commitment to scientific research and development drives their goal to create effective, safe, and accessible cellular therapies for a better quality of life. Read More
News & Press Releases
(BPT) - Whether it's served hot or iced, sweetened or black, coffee remains one of the most popular beverages in the United States - and the world. According to Drive Research, 73% of Americans enjoy coffee daily, and a whopping 93% consume it at least once per week. But the cost of this favorite drink keeps increasing, putting the rapidly growing $130 billion coffee industry at risk as global warming could reduce available viable land for coffee cultivation up to 50% by 2050. Coffee consumption has skyrocketed 60% over the last 30 years, resulting in significant environmental damage in coffee-growing regions, including deforestation, increased water usage and extensive pesticide use.
Via Brandpoint · April 16, 2025

NEW YORK, NY / ACCESSWIRE / December 3, 2024 / Investor Summit Group, committed to advancing the MicroCap and SmallCap investment community, announces that the November 21, 2024 Winter Investor Summit Virtual Conference presentations are now available for on-demand viewing.
Via ACCESSWIRE · December 3, 2024

HAIFA, ISRAEL / ACCESSWIRE / November 12, 2024 / Pluri Inc. (NASDAQ:PLUR), a leading biotechnology company that offers cell-based solutions for various industries. The company will be available for 1-on-1 meetings throughout the day in addition to their presentation.
Via ACCESSWIRE · November 12, 2024

NEW YORK, NY / ACCESSWIRE / September 11, 2024 / Investor Summit Group, an independent organization focused on creating networking opportunities for the MicroCap and SmallCap community, has announced that presentations from the August 20 Microcap Investor Summit Virtual 2024 Conference are now accessible for on-demand viewing.
Via ACCESSWIRE · September 11, 2024

Pluri just reported results for the fourth quarter of 2023.
Via InvestorPlace · April 3, 2024

Via Benzinga · April 25, 2024

Via Benzinga · April 8, 2024

Via Benzinga · April 8, 2024

Via Benzinga · January 24, 2024

Via Benzinga · January 23, 2024

We're starting off Tuesday with a breakdown of the biggest pre-market stock movers traders will want to keep an eye on this morning!
Via InvestorPlace · January 23, 2024

Via Benzinga · October 31, 2023

Via Benzinga · July 31, 2023

Pluri Inc. (NASDAQ: PLUR) has signed a three-year, $4.2 million contract with the U.S.
Via Benzinga · July 11, 2023

Via Benzinga · June 6, 2023

Via Benzinga · March 24, 2023
12 Health Care Stocks Moving In Friday's After-Market Sessionbenzinga.com
Via Benzinga · January 13, 2023

During Friday, 125 stocks hit new 52-week lows.
Via Benzinga · October 28, 2022